Related Experiment Videos
RNA recognition by autoantigens and autoantibodies
1Department of Microbiology, Duke University Medical Center, Durham, NC 27710, USA.
Molecular Biology Reports
|January 1, 1996
Summary
Autoantibodies targeting La, Ro, Sm, and RNP autoantigens are linked to autoimmune diseases. Molecular studies reveal RNA binding and potential cross-reactivity with infectious agents, suggesting mimetic processes in autoimmunity.
Area of Science:
- Immunology
- Molecular Biology
- Rheumatology
Background:
- La, Ro, Sm, and RNP autoantigens are key targets in autoimmune disease research.
- These autoantigens bind to RNA, often within RNP particles, and possess a common RNA Recognition Motif (RRM).
- Autoantibodies against these antigens correlate with specific connective tissue diseases like Sjogren's syndrome and systemic lupus erythematosus.
Purpose of the Study:
- To review the molecular and immunological characteristics of La, Ro, Sm, and RNP autoantigens.
- To explore the mechanisms of autoantibody induction, including direct antigen presentation and molecular mimicry.
- To discuss the role of RNA as an autoantigen and the recognition of conformational epitopes.
Main Methods:
- Analysis of cDNA encoding autoantigens.
- Molecular studies of RNA-binding domains, including RRM structure.
- Immunological analysis of patient sera using recombinant autoantigens.
- Review of existing literature on autoantibody induction and cross-reactivity.
Main Results:
- Common RNA Recognition Motif (RRM) identified in autoantigens.
- Multiple continuous and discontinuous epitopes found on autoantigens.
- Evidence supports direct presentation of autoantigens and potential cross-reactivity with infectious agents.
- RNA molecules can act as autoantigens, recognized by RNP autoantibodies.
Conclusions:
- Autoantibody induction likely involves direct antigen presentation and potentially molecular mimicry.
- RNA itself can be an autoantigen, with conformational epitopes recognized by autoantibodies.
- Mimetic processes may play a role in initiating autoimmune responses to RNA structures.